Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug for cancer patients in the United State…
$1.34+2.29%
报价 2026-11-09
市值
$185,033
EV
$5.3M
PE (TTM)
–
预期 PE
–
52 周区间距高点 -84.7%
$0.92$8.74
筛选结果
pipeline · 2026-11-09Filter✗ 高增长✗ Cheap✗ GARP
excluded industry: Biotechnology
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
同行业市值相近 · Biotechnology| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| PPBTPurple Biotech Ltd. | $185,033 | +2.3% | – | 0% | – | – | – | |
| MTNBMatinas BioPharma Holdings, Inc. | $529,578 | +4.2% | +46.0% | 0% | – | – | – | |
| CDTCDT Equity Inc. | $391,604 | -35.9% | – | 38.7% | – | 4.6x | – | |
| HCWBHCW Biologics Inc. | $331,650 | -6.5% | -86.6% | 95.9% | – | – | – | |
| HLSQTessera Defense and Homeland Security Inc | $312,858 | -13.6% | – | – | – | – | – | |
| SPRCSciSparc Ltd. | $241,394 | -0.7% | – | 64.5% | – | – | – | |
| SCNIScinai Immunotherapeutics Ltd. | $239,032 | +4.9% | – | -252.5% | – | – | – | |
| BDRXBiodexa Pharmaceuticals Plc | $229,429 | -0.8% | – | 0% | – | – | – | |
| NIKINiki BioSolutions, Inc. | $140,072 | +8.9% | – | 0% | – | – | – | |
| 同行中位数 | – | – | -20.3% | 0% | – | 4.6x | – |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。